Temocillin vs Meropenem for the Treatment of Third Generation Cephalosporin-Resistant Enterobacterial Bacteremia: A Randomized and Pragmatic Trial
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: PUBLIC ANDALUSIAN FOUNDATION FOR THE MANAGEMENT OF HEALTH RESEARCH IN SEVILLE
- Phase: III
- Execution start: 20/10/2020
- End of execution: 30/10/2020
- IP: MIGUEL ANGEL LOPEZ RUZ